NPI: 1518138916 · KNOXVILLE, TN 37912 · Pediatrics Physician · NPI assigned 03/13/2008
Authorized official MAYNARD, BETH controls 20+ related entities in our dataset. Read more
| Authorized Official | MAYNARD, BETH (VICE PRESIDENT) |
| NPI Enumeration Date | 03/13/2008 |
Other providers sharing the same authorized official: MAYNARD, BETH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 102,726 | $2.47M |
| 2019 | 119,360 | $2.81M |
| 2020 | 103,433 | $2.36M |
| 2021 | 123,372 | $2.77M |
| 2022 | 109,275 | $2.41M |
| 2023 | 102,223 | $2.15M |
| 2024 | 84,615 | $1.76M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 55,301 | 47,431 | $4.08M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 78,806 | 67,918 | $3.85M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 34,407 | 29,374 | $1.67M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 20,217 | 18,015 | $1.61M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 21,326 | 18,479 | $1.50M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11,427 | 9,992 | $873K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 23,794 | 16,452 | $556K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3,494 | 2,941 | $297K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 35,897 | 30,389 | $272K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 20,823 | 9,284 | $229K |
| 92552 | 10,693 | 8,921 | $217K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 19,470 | 17,326 | $214K |
| 96161 | 14,882 | 12,489 | $198K | |
| 96127 | 40,299 | 26,744 | $190K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8,551 | 7,538 | $126K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 4,756 | 4,158 | $91K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2,424 | 2,017 | $89K |
| 99381 | 1,077 | 877 | $78K | |
| 36416 | 40,350 | 33,632 | $59K | |
| 99173 | 11,285 | 9,294 | $59K | |
| 80061 | Lipid panel | 3,937 | 3,332 | $58K |
| 1160F | 66,618 | 55,091 | $44K | |
| 83655 | 3,746 | 3,134 | $44K | |
| 1159F | 63,771 | 52,818 | $41K | |
| 69210 | 1,050 | 826 | $40K | |
| 96160 | 2,947 | 2,390 | $38K | |
| 81003 | 15,469 | 12,376 | $29K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 904 | 781 | $28K |
| 3008F | 14,151 | 11,619 | $20K | |
| 99383 | 250 | 164 | $19K | |
| 90670 | 14,571 | 12,758 | $16K | |
| 99382 | 191 | 129 | $16K | |
| 90461 | 21,898 | 19,013 | $16K | |
| 90474 | 854 | 741 | $9K | |
| 90716 | 4,271 | 3,703 | $8K | |
| 90707 | 4,685 | 4,034 | $6K | |
| 85018 | 2,646 | 2,057 | $5K | |
| 99384 | 55 | 34 | $5K | |
| 90677 | 1,420 | 1,344 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 189 | 156 | $4K |
| 90723 | 11,406 | 10,067 | $4K | |
| 90651 | 805 | 644 | $4K | |
| 90633 | 5,364 | 4,636 | $3K | |
| 90686 | 8,185 | 7,121 | $3K | |
| 82948 | 569 | 475 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 847 | 767 | $2K |
| 90734 | 523 | 443 | $2K | |
| 90647 | 8,665 | 7,685 | $2K | |
| 99401 | 64 | 45 | $1K | |
| 90681 | 2,976 | 2,637 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 72 | 57 | $1K |
| 90680 | 1,471 | 1,237 | $897.25 | |
| 90696 | 623 | 534 | $480.50 | |
| 90648 | 3,295 | 2,833 | $217.35 | |
| 90700 | 497 | 408 | $157.80 | |
| 86308 | 21 | 18 | $90.52 | |
| 82272 | 19 | 13 | $43.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 14 | 12 | $16.42 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 1,633 | 1,422 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 214 | 202 | $0.00 |
| 3351F | 638 | 571 | $0.00 | |
| 90688 | 1,608 | 1,373 | $0.00 | |
| 3048F | 692 | 578 | $0.00 | |
| 90674 | 199 | 175 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 15 | 13 | $0.00 |
| 3352F | 35 | 14 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 2,052 | 1,875 | $0.00 |
| 99072 | 7,608 | 6,118 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 1,265 | 1,148 | $0.00 |
| 4274F | 381 | 360 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 17 | 13 | $0.00 |
| 90715 | 116 | 99 | $0.00 | |
| 90685 | 213 | 201 | $0.00 |